http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008228646-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a177f0fa84b1b2134e13caa36974ce3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fbcdb105756f552ddf2e9ae2cfcf40a |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
filingDate | 2007-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f00d7643c5bb8bd39ed4ab02be155e8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8115722cb8ffe3cc185c59108621bcc4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a37f38c79b12bf7574fef89a832e358d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47ee1fddd825262016db981d7524b793 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0aaed8cb36340fb0146e60391221f79f |
publicationDate | 2008-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2008228646-A |
titleOfInvention | Type 2 diabetes diagnostic agent |
abstract | PROBLEM TO BE SOLVED: To provide a diagnostic agent for use in diagnosis of type 2 diabetes, a diagnostic kit for type 2 diabetes, a method for screening a substance having a preventive and / or therapeutic agent for type 2 diabetes, and a kit used in the screening provide. [Solution] It consists of a nucleic acid that hybridizes under stringent conditions to a base sequence of at least one gene selected from 38 types of genes and / or a specific antibody or fragment thereof that binds to a protein encoded by any of the genes. A diagnostic agent for type 2 diabetes is provided. The diagnostic agent provided by the present invention is for confirming the expression of a gene associated with the onset of type 2 diabetes in white blood cells, and the gene provided in the present invention is used for the conventional diagnosis of type 2 diabetes. By substituting for the gene that can be used or in addition to these genes, the accuracy of the determination that the subject can be type 2 diabetes or future type 2 diabetes can be further increased. [Selection figure] None |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014001451-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012533065-A |
priorityDate | 2007-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 556.